Vivos Therapeutics Inc
NASDAQ:VVOS
Earnings Announcements
Vivos Therapeutics Reports Fourth Quarter And Full Year 2021 Financial Results And Operational Update
Published: 03/31/2022 20:57 GMT
Vivos Therapeutics Inc (VVOS) - Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update.
Q4 Revenue Rose 33 Percent to $4.4 Million.
Q4 Revenue Rose 33 Percent to $4.4 Million.
Revenue is expected to be $3.81 Million
Adjusted EPS is expected to be -$0.28
Next Quarter Revenue Guidance is expected to be $4.16 Million
Next Quarter EPS Guidance is expected to be -$0.27
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.28
Next Quarter Revenue Guidance is expected to be $4.16 Million
Next Quarter EPS Guidance is expected to be -$0.27
More details on our Analysts Page.